Conflicts of Interest

  • Christine LaineEmail author


Conflicts of interest in biomedicine have perhaps existed in some form since the dawn of medicine with healers more apt to recommend therapies whose use would lead to some benefit for the healer, whether directly through financial gain or indirectly through gains in reputation and prestige. However, over recent decades, conflicts of interest and their potential to bias the medical literature and, consequently, medical practice have grown in frequency and degree [1]. For this reason, the management of potential conflicts of interest has become a critical component in the communication and publication of biomedical science. Editors, publishers, researchers, peer reviewers and funders are among the involved stakeholders who must be aware of conflicts of interest and cooperate in managing conflicts in an ethical and transparent manner.


  1. 1.
    Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician–industry relationships. N Engl J Med. 2007;356:1742–50.CrossRefPubMedGoogle Scholar
  2. 2.
  3. 3.
    Davidoff F. Where’s the bias? Ann Intern Med. 1997;126:986–8.CrossRefPubMedGoogle Scholar
  4. 4.
  5. 5.
    ICMJE Conflict of disclosure form. Accessed 1 May 2015.
  6. 6.
    Lo B, Field MJ, editors. Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press (US); 2009.Google Scholar
  7. 7.
    Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289:454–65.CrossRefPubMedGoogle Scholar
  8. 8.
    Friedman LS, Richter ED. Relationship between conflicts of interest and research results. J Gen Intern Med. 2004;19:51–6.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Tereskerz PM, Hamric AB, Guterbock TM, Moreno JD. Prevalence of industry support and its relationship to research integrity. Account Res. 2009;16:78–105.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kjaergard LL, Als-Nielsen B. Association between competing interests and authors’ conclusions: epidemiological study of randomized clinical trials published in BMJ. BMJ. 2002;325:249.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennet CL, Adams JR, et al. The uncertainty principle and industry-sponsored research. Lancet. 2000;356:635–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Drazen JM. Revisiting the commercial–academic interface. N Engl J Med. 2015;372:1853–4.CrossRefPubMedGoogle Scholar
  13. 13.
    Zerhouni EA. Translational and clinical science—time for a new vision. N Engl J Med. 2005;353:1621–3.CrossRefPubMedGoogle Scholar
  14. 14.
    Gulbrandsen M, Smeby JC. Industry funding and university professors’ research performance. Res Policy. 2005;34:932–50.CrossRefGoogle Scholar
  15. 15.
    Davidoff F, DeAngelis CD, Drazen JM, Hoey J, Højgaard L, Horton R, et al. Sponsorship, authorship, and accountability. Ann Intern Med. 2001;135:463–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Drazen JM, Van der Weyden MB, Sahni P, Rosenberg J, Marusic A, Laine C, et al. Uniform format for disclosure of competing interests in ICMJE journals. Ann Intern Med. 2010;152:125–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Drazen JM, de Leeuw PW, Laine C, Mulrow CD, DeAngelis CD, Frizelle FA, et al. Toward more uniform conflict disclosures: the updated ICMJE conflict of interest reporting form. Ann Intern Med. 2010;153:268–9.CrossRefPubMedGoogle Scholar
  18. 18.
    The Editors. Publishing commentary by authors with potential conflicts of interest: when, why, and how. Ann Intern Med. 2004;141:73–4.CrossRefGoogle Scholar
  19. 19.
    Angell M, Kassirer JP. Editorials and conflicts of interest. N Engl J Med. 1996;335:1055–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Drazen JM, Curfman GD. Financial associations of authors. N Engl J Med. 2002;346:1901–2.CrossRefPubMedGoogle Scholar
  21. 21.
    Brockway LM, Furcht LT. Conflicts of interest in biomedical research—the FASEB guidelines. FASEB J. 2006;20:2435–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Wager E, Kleinert S. Chapter 50: Responsible research publication: International standards for authors. A position statement developed at the 2nd World Conference on Research Integrity, Singapore, 22–24 July 2010. In: Mayer T, Steneck N, editors. Promoting research integrity in a global environment. Singapore: Imperial College Press/World Scientific Publishing; 2011. p. 309–16. ISBN: 978-981-4340-97-7.Google Scholar
  23. 23.
    Battisti WP, Wager E, Baltzer L, Bridges D, Cairns A, Carswell CI, et al. Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med. 2015;163:461–4. Scholar

Copyright information

© The National Medical Journal of India 2018

Authors and Affiliations

  1. 1.Annals of Internal Medicine and American College of PhysiciansPhiladelphiaUSA

Personalised recommendations